Global Nuclear Medicine/ Radiopharmaceuticals Market Size study, by Type (Diagnostic Nuclear Medicine and Therapeutic Nuclear Medicine), Application (Diagnostic Application and Therapeutic Application), by Procedural Volume (Diagnostic procedures and Therapeutic procedures) and Regional Forecasts 2019-2026
- BIZ3510755
- 200 Pages
- February 2020
- Energy and Power
The regional analysis of global Nuclear Medicine/ Radiopharmaceuticals market is considered for the key regions such as Asia Pacific, North America, Europe, Latin America and Rest of the World. North America accounts for the largest share in the global Nuclear Medicine market due to the increased better infrastructure facility in the health care sector. Similarly, North America is the fastest growing region in the market owing to the effectiveness of a diagnosis procedure for the early detection such as cancer and cardiac diseases.
Market player included in this report are:
Cardinal Health
Positron Corporation
GE Healthcare
Curium
Lantheus Medical Imaging
Bayer
Bracco Imaging
Eczacibasi-Monrol Nuclear Products
Nordion
Advanced Accelerator Applications
The objective of the study is to define market sizes of different segments & countries in recent years and to forecast the values to the coming eight years. The report is designed to incorporate both qualitative and quantitative aspects of the industry within each of the regions and countries involved in the study. Furthermore, the report also caters the detailed information about the crucial aspects such as driving factors & challenges which will define the future growth of the market. Additionally, the report shall also incorporate available opportunities in micro markets for stakeholders to invest along with the detailed analysis of competitive landscape and product offerings of key players. The detailed segments and sub-segment of the market are explained below:
By Type:
Diagnostic Nuclear Medicine
Therapeutic Nuclear Medicine
By Application:
Diagnostic Application
Therapeutic application
By Procedural Volume:
Diagnostic procedures
Therapeutic procedures
By Regions:
North America
U.S.
Canada
Europe
UK
Germany
Asia Pacific
China
India
Japan
Latin America
Brazil
Mexico
Rest of the World
Furthermore, years considered for the study are as follows:
Historical year – 2016, 2017
Base year – 2018
Forecast period – 2019 to 2026
Target Audience of the Global Nuclear Medicine/ Radiopharmaceuticals Market in Market Study:
Key Consulting Companies & Advisors
Large, medium-sized, and small enterprises
Venture capitalists
Value-Added Resellers (VARs)
Third-party knowledge providers
Investment bankers
Investors
1.1. Market Snapshot
1.2. Global & Segmental Market Estimates & Forecasts, 2017-2026 (USD Billion)
1.2.1. Nuclear Medicine/ Radiopharmaceuticals Market, by Region, 2017-2026 (USD Billion)
1.2.2. Nuclear Medicine/ Radiopharmaceuticals Market, by Type ,2017-2026 (USD Billion)
1.2.3. Nuclear Medicine/ Radiopharmaceuticals Market, by Application,2017-2026 (USD Billion)
1.2.4. Nuclear Medicine/ Radiopharmaceuticals Market, by Procedural Volume, 2017-2026 (USD Billion)
1.3. Key Trends
1.4. Estimation Methodology
1.5. Research Assumption
Chapter 2. Global Nuclear Medicine/ Radiopharmaceuticals Market Definition and Scope
2.1. Objective of the Study
2.2. Market Definition & Scope
2.2.1. Scope of the Study
2.2.2. Industry Evolution
2.3. Years Considered for the Study
2.4. Currency Conversion Rates
Chapter 3. Global Nuclear Medicine/ Radiopharmaceuticals Market Dynamics
3.1. Nuclear Medicine/ Radiopharmaceuticals Market Impact Analysis (2018-2026)
3.1.1. Market Drivers
3.1.2. Market Challenges
3.1.3. Market Opportunities
Chapter 4. Global Nuclear Medicine/ Radiopharmaceuticals Market Industry Analysis
4.1. Porter’s 5 Force Model
4.1.1. Bargaining Power of Suppliers
4.1.2. Bargaining Power of Buyers
4.1.3. Threat of New Entrants
4.1.4. Threat of Substitutes
4.1.5. Competitive Rivalry
4.1.6. Futuristic Approach to Porter’s 5 Force Model (2016-2026)
4.2. PEST Analysis
4.2.1. Political
4.2.2. Economical
4.2.3. Social
4.2.4. Technological
4.3. Investment Adoption Model
4.4. Analyst Recommendation & Conclusion
Chapter 5. Global Nuclear Medicine/ Radiopharmaceuticals Market, by Type
5.1. Market Snapshot
5.2. Global Nuclear Medicine/ Radiopharmaceuticals Market by Type, Performance - Potential Analysis
5.3. Global Nuclear Medicine/ Radiopharmaceuticals Market Estimates & Forecasts by Type 2016-2026 (USD Billion)
5.4. Nuclear Medicine/ Radiopharmaceuticals Market, Sub Segment Analysis
5.4.1. Diagnostic Nuclear Medicine
5.4.2. Therapeutic Nuclear Medicine
Chapter 6. Global Nuclear Medicine/ Radiopharmaceuticals Market, by Application
6.1. Market Snapshot
6.2. Global Nuclear Medicine/ Radiopharmaceuticals Market by Application, Performance - Potential Analysis
6.3. Global Nuclear Medicine/ Radiopharmaceuticals Market Estimates & Forecasts by Application 2016-2026 (USD Billion)
6.4. Nuclear Medicine/ Radiopharmaceuticals Market, Sub Segment Analysis
6.4.1. Diagnostic Application
6.4.2. Therapeutic Application
Chapter 7. Global Nuclear Medicine/ Radiopharmaceuticals Market, by Procedural Volume
7.1. Market Snapshot
7.2. Global Nuclear Medicine/ Radiopharmaceuticals Market by Procedural Volume, Performance - Potential Analysis
7.3. Global Nuclear Medicine/ Radiopharmaceuticals Market Estimates & Forecasts by Procedural Volume 2016-2026 (USD Billion)
7.4. Nuclear Medicine/ Radiopharmaceuticals Market, Sub Segment Analysis
7.4.1. Diagnostic procedures
7.4.2. Therapeutic procedures
Chapter 8. Global Nuclear Medicine/ Radiopharmaceuticals Market, Regional Analysis
8.1. Nuclear Medicine/ Radiopharmaceuticals Market, Regional Market Snapshot
8.2. North America Nuclear Medicine/ Radiopharmaceuticals Market
8.2.1. U.S. Nuclear Medicine/ Radiopharmaceuticals Market
8.2.1.1. Type breakdown estimates & forecasts, 2016-2026
8.2.1.2. Application breakdown estimates & forecasts, 2016-2026
8.2.1.3. Procedural Volume breakdown estimates & forecasts, 2016-2026
8.2.2. Canada Nuclear Medicine/ Radiopharmaceuticals Market
8.3. Europe Nuclear Medicine/ Radiopharmaceuticals Market Snapshot
8.3.1. U.K. Nuclear Medicine/ Radiopharmaceuticals Market
8.3.2. Rest of Europe Nuclear Medicine/ Radiopharmaceuticals Market
8.4. Asia-Pacific Nuclear Medicine/ Radiopharmaceuticals Market Snapshot
8.4.1. China Nuclear Medicine/ Radiopharmaceuticals Market
8.4.2. India Nuclear Medicine/ Radiopharmaceuticals Market
8.4.3. Japan Nuclear Medicine/ Radiopharmaceuticals Market
8.4.4. Rest of Asia Pacific Nuclear Medicine/ Radiopharmaceuticals Market
8.5. Latin America Nuclear Medicine/ Radiopharmaceuticals Market Snapshot
8.5.1. Brazil Nuclear Medicine/ Radiopharmaceuticals Market
8.5.2. Mexico Nuclear Medicine/ Radiopharmaceuticals Market
8.6. Rest of The World Nuclear Medicine/ Radiopharmaceuticals Market
Chapter 9. Competitive Intelligence
9.1. Top Market Strategies
9.2. Company Profiles
9.2.1. Cardinal Health
9.2.1.1. Key Information
9.2.1.2. Overview
9.2.1.3. Financial (Subject to Data Availability)
9.2.1.4. Product Summary
9.2.1.5. Recent Developments
9.2.2. GE Healthcare
9.2.3. Curium
9.2.4. Lantheus Medical Imaging
9.2.5. Bayer
9.2.6. Bracco Imaging
9.2.7. Eczacibasi-Monrol Nuclear Products
9.2.8. Nordion
9.2.9. Advanced Accelerator Applications
9.2.10. Positron Corporation
Chapter 10. Research Process
10.1. Research Process
10.1.1. Data Mining
10.1.2. Analysis
10.1.3. Market Estimation
10.1.4. Validation
10.1.5. Publishing
10.2. Research Attributes
10.3. Research Assumption
TABLE 2. LIST OF PRIMARY SOURCES, USED IN THE STUDY OF GLOBAL NUCLEAR MEDICINE/ RADIOPHARMACEUTICALS MARKET
TABLE 3. GLOBAL NUCLEAR MEDICINE/ RADIOPHARMACEUTICALS MARKET, REPORT SCOPE
TABLE 4. YEARS CONSIDERED FOR THE STUDY
TABLE 5. EXCHANGE RATES CONSIDERED
TABLE 6. GLOBAL NUCLEAR MEDICINE/ RADIOPHARMACEUTICALS MARKET ESTIMATES & FORECASTS BY REGION 2016-2026 (USD BILLION)
TABLE 7. GLOBAL NUCLEAR MEDICINE/ RADIOPHARMACEUTICALS MARKET ESTIMATES & FORECASTS BY TYPE 2016-2026 (USD BILLION)
TABLE 8. GLOBAL NUCLEAR MEDICINE/ RADIOPHARMACEUTICALS MARKET ESTIMATES & FORECASTS BY APPLICATION 2016-2026 (USD BILLION)
TABLE 9. GLOBAL NUCLEAR MEDICINE/ RADIOPHARMACEUTICALS MARKET ESTIMATES & FORECASTS BY PROCEDURAL VOLUME 2016-2026 (USD BILLION)
TABLE 10. GLOBAL NUCLEAR MEDICINE/ RADIOPHARMACEUTICALS MARKET BY SEGMENT, ESTIMATES & FORECASTS, 2016-2026 (USD BILLION)
TABLE 11. GLOBAL NUCLEAR MEDICINE/ RADIOPHARMACEUTICALS MARKET BY REGION, ESTIMATES & FORECASTS, 2016-2026 (USD BILLION)
TABLE 12. GLOBAL NUCLEAR MEDICINE/ RADIOPHARMACEUTICALS MARKET BY SEGMENT, ESTIMATES & FORECASTS, 2016-2026 (USD BILLION)
TABLE 13. GLOBAL NUCLEAR MEDICINE/ RADIOPHARMACEUTICALS MARKET BY REGION, ESTIMATES & FORECASTS, 2016-2026 (USD BILLION)
TABLE 14. GLOBAL NUCLEAR MEDICINE/ RADIOPHARMACEUTICALS MARKET BY SEGMENT, ESTIMATES & FORECASTS, 2016-2026 (USD BILLION)
TABLE 15. GLOBAL NUCLEAR MEDICINE/ RADIOPHARMACEUTICALS MARKET BY REGION, ESTIMATES & FORECASTS, 2016-2026 (USD BILLION)
TABLE 16. GLOBAL NUCLEAR MEDICINE/ RADIOPHARMACEUTICALS MARKET BY SEGMENT, ESTIMATES & FORECASTS, 2016-2026 (USD BILLION)
TABLE 17. GLOBAL NUCLEAR MEDICINE/ RADIOPHARMACEUTICALS MARKET BY REGION, ESTIMATES & FORECASTS, 2016-2026 (USD BILLION)
TABLE 18. GLOBAL NUCLEAR MEDICINE/ RADIOPHARMACEUTICALS MARKET BY SEGMENT, ESTIMATES & FORECASTS, 2016-2026 (USD BILLION)
TABLE 19. GLOBAL NUCLEAR MEDICINE/ RADIOPHARMACEUTICALS MARKET BY REGION, ESTIMATES & FORECASTS, 2016-2026 (USD BILLION)
TABLE 20. U.S. NUCLEAR MEDICINE/ RADIOPHARMACEUTICALS MARKET ESTIMATES & FORECASTS, 2016-2026 (USD BILLION)
TABLE 21. U.S. NUCLEAR MEDICINE/ RADIOPHARMACEUTICALS MARKET ESTIMATES & FORECASTS BY SEGMENT 2016-2026 (USD BILLION)
TABLE 22. U.S. NUCLEAR MEDICINE/ RADIOPHARMACEUTICALS MARKET ESTIMATES & FORECASTS BY SEGMENT 2016-2026 (USD BILLION)
TABLE 23. CANADA NUCLEAR MEDICINE/ RADIOPHARMACEUTICALS MARKET ESTIMATES & FORECASTS, 2016-2026 (USD BILLION)
TABLE 24. CANADA NUCLEAR MEDICINE/ RADIOPHARMACEUTICALS MARKET ESTIMATES & FORECASTS BY SEGMENT 2016-2026 (USD BILLION)
TABLE 25. CANADA NUCLEAR MEDICINE/ RADIOPHARMACEUTICALS MARKET ESTIMATES & FORECASTS BY SEGMENT 2016-2026 (USD BILLION)
TABLE 26. UK NUCLEAR MEDICINE/ RADIOPHARMACEUTICALS MARKET ESTIMATES & FORECASTS, 2016-2026 (USD BILLION)
TABLE 27. UK NUCLEAR MEDICINE/ RADIOPHARMACEUTICALS MARKET ESTIMATES & FORECASTS BY SEGMENT 2016-2026 (USD BILLION)
TABLE 28. UK NUCLEAR MEDICINE/ RADIOPHARMACEUTICALS MARKET ESTIMATES & FORECASTS BY SEGMENT 2016-2026 (USD BILLION)
TABLE 29. GERMANY NUCLEAR MEDICINE/ RADIOPHARMACEUTICALS MARKET ESTIMATES & FORECASTS, 2016-2026 (USD BILLION)
TABLE 30. GERMANY NUCLEAR MEDICINE/ RADIOPHARMACEUTICALS MARKET ESTIMATES & FORECASTS BY SEGMENT 2016-2026 (USD BILLION)
TABLE 31. GERMANY NUCLEAR MEDICINE/ RADIOPHARMACEUTICALS MARKET ESTIMATES & FORECASTS BY SEGMENT 2016-2026 (USD BILLION)
TABLE 32. ROE NUCLEAR MEDICINE/ RADIOPHARMACEUTICALS MARKET ESTIMATES & FORECASTS, 2016-2026 (USD BILLION)
TABLE 33. ROE NUCLEAR MEDICINE/ RADIOPHARMACEUTICALS MARKET ESTIMATES & FORECASTS BY SEGMENT 2016-2026 (USD BILLION)
TABLE 34. ROE NUCLEAR MEDICINE/ RADIOPHARMACEUTICALS MARKET ESTIMATES & FORECASTS BY SEGMENT 2016-2026 (USD BILLION)
TABLE 35. CHINA NUCLEAR MEDICINE/ RADIOPHARMACEUTICALS MARKET ESTIMATES & FORECASTS, 2016-2026 (USD BILLION)
TABLE 36. CHINA NUCLEAR MEDICINE/ RADIOPHARMACEUTICALS MARKET ESTIMATES & FORECASTS BY SEGMENT 2016-2026 (USD BILLION)
TABLE 37. CHINA NUCLEAR MEDICINE/ RADIOPHARMACEUTICALS MARKET ESTIMATES & FORECASTS BY SEGMENT 2016-2026 (USD BILLION)
TABLE 38. INDIA NUCLEAR MEDICINE/ RADIOPHARMACEUTICALS MARKET ESTIMATES & FORECASTS, 2016-2026 (USD BILLION)
TABLE 39. INDIA NUCLEAR MEDICINE/ RADIOPHARMACEUTICALS MARKET ESTIMATES & FORECASTS BY SEGMENT 2016-2026 (USD BILLION)
TABLE 40. INDIA NUCLEAR MEDICINE/ RADIOPHARMACEUTICALS MARKET ESTIMATES & FORECASTS BY SEGMENT 2016-2026 (USD BILLION)
TABLE 41. JAPAN NUCLEAR MEDICINE/ RADIOPHARMACEUTICALS MARKET ESTIMATES & FORECASTS, 2016-2026 (USD BILLION)
TABLE 42. JAPAN NUCLEAR MEDICINE/ RADIOPHARMACEUTICALS MARKET ESTIMATES & FORECASTS BY SEGMENT 2016-2026 (USD BILLION)
TABLE 43. JAPAN NUCLEAR MEDICINE/ RADIOPHARMACEUTICALS MARKET ESTIMATES & FORECASTS BY SEGMENT 2016-2026 (USD BILLION)
TABLE 44. ROAPAC NUCLEAR MEDICINE/ RADIOPHARMACEUTICALS MARKET ESTIMATES & FORECASTS, 2016-2026 (USD BILLION)
TABLE 45. ROAPAC NUCLEAR MEDICINE/ RADIOPHARMACEUTICALS MARKET ESTIMATES & FORECASTS BY SEGMENT 2016-2026 (USD BILLION)
TABLE 46. ROAPAC NUCLEAR MEDICINE/ RADIOPHARMACEUTICALS MARKET ESTIMATES & FORECASTS BY SEGMENT 2016-2026 (USD BILLION)
TABLE 47. BRAZIL NUCLEAR MEDICINE/ RADIOPHARMACEUTICALS MARKET ESTIMATES & FORECASTS, 2016-2026 (USD BILLION)
TABLE 48. BRAZIL NUCLEAR MEDICINE/ RADIOPHARMACEUTICALS MARKET ESTIMATES & FORECASTS BY SEGMENT 2016-2026 (USD BILLION)
TABLE 49. BRAZIL NUCLEAR MEDICINE/ RADIOPHARMACEUTICALS MARKET ESTIMATES & FORECASTS BY SEGMENT 2016-2026 (USD BILLION)
TABLE 50. MEXICO NUCLEAR MEDICINE/ RADIOPHARMACEUTICALS MARKET ESTIMATES & FORECASTS, 2016-2026 (USD BILLION)
TABLE 51. MEXICO NUCLEAR MEDICINE/ RADIOPHARMACEUTICALS MARKET ESTIMATES & FORECASTS BY SEGMENT 2016-2026 (USD BILLION)
TABLE 52. MEXICO NUCLEAR MEDICINE/ RADIOPHARMACEUTICALS MARKET ESTIMATES & FORECASTS BY SEGMENT 2016-2026 (USD BILLION)
TABLE 53. ROLA NUCLEAR MEDICINE/ RADIOPHARMACEUTICALS MARKET ESTIMATES & FORECASTS, 2016-2026 (USD BILLION)
TABLE 54. ROLA NUCLEAR MEDICINE/ RADIOPHARMACEUTICALS MARKET ESTIMATES & FORECASTS BY SEGMENT 2016-2026 (USD BILLION)
TABLE 55. ROLA NUCLEAR MEDICINE/ RADIOPHARMACEUTICALS MARKET ESTIMATES & FORECASTS BY SEGMENT 2016-2026 (USD BILLION)
TABLE 56. ROW NUCLEAR MEDICINE/ RADIOPHARMACEUTICALS MARKET ESTIMATES & FORECASTS, 2016-2026 (USD BILLION)
TABLE 57. ROW NUCLEAR MEDICINE/ RADIOPHARMACEUTICALS MARKET ESTIMATES & FORECASTS BY SEGMENT 2016-2026 (USD BILLION)
TABLE 58. ROW NUCLEAR MEDICINE/ RADIOPHARMACEUTICALS MARKET ESTIMATES & FORECASTS BY SEGMENT 2016-2026 (USD BILLION)
Similar Reports
Summary Based on products type, the report describes major products type share of regional market. Products mentioned as follows: By Type ?1 KW 1 KW-5 KW Based on region, the report describes major regions market by vendor, products and Application. Regions mentioned as follows: Europe North America China Japan & Korea India Based on Application, the report describes major Application shar...
- Publish Date: April 1, 2017
- $800
The turbine generator market is expected to witness strong growth with government taking favourable initiatives to support the power sector. The report provides a brief overview of the turbine generator market in India, the market size and growth in value and volume terms has been provided. It also includes the market segmentation. An analysis of the drivers reveals that rise in overall power ...
- Publish Date: January 18, 2011
- $950
The natural gas market in India is witnessing growth and capacity expansions to meet the growing demand for gas consumption as a result of growth in industrial, auto and commercial sector. Increased economic activity is providing the players an opportunity for growth and expansion. The report provides a brief introduction to the natural gas industry. The market overview includes information rega...
- Publish Date: July 19, 2011
- $950
